✦ LIBER ✦

Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia

✍ Scribed by Kocheril, S. V. ;Appleton, B. E. ;Somers, E. C. ;Kazerooni, E. A. ;Flaherty, K. R. ;Martinez, F. J. ;Gross, B. H. ;Crofford, L. J.

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 166 KB
Volume: 53
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diagnosis of interstitial lung disease

✍ Andrew Bush 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB 👁 1 views

Interstitial lung disease in connective

Interstitial lung disease in connective tissue diseases: What are the important questions?

✍ RYU, JAY H. ;BONGARTZ, TIM ;MATTESON, ERIC L. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

Incidence and mortality of interstitial

Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study

✍ Tim Bongartz; Carlotta Nannini; Yimy F. Medina-Velasquez; Sara J. Achenbach; Cyn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Treatment of Lupus Interstitial Lung Dis

Treatment of Lupus Interstitial Lung Disease with Intravenous Cyclophosphamide

✍ Arnold R. Eiser; Harvey M. Shanies 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

Intravenous pulse cyclophosphamide (IPC) was used to treat lupus interstitial lung disease in 2 patients. Vital capacity increased by 67-110% of baseline values with IPC treatment. Total lung capacity and diffusing capacity also improved. Dyspnea and other manifestations of lupus improved dramatical

Treatment of antisynthetase-associated i

Treatment of antisynthetase-associated interstitial lung disease with tacrolimus

✍ Margaret R. Wilkes; Susan M. Sereika; Noreen Fertig; Mary R. Lucas; Chester V. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract ## Objective To assess the efficacy of tacrolimus in patients with anti–aminoacyl–transfer RNA synthetase (anti‐aaRS)–associated interstitial lung disease (ILD) and idiopathic inflammatory myopathy (IIM). ## Methods Ninety‐eight patients with anti‐aaRS autoantibodies were identified

Leflunomide use and the risk of intersti

Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis

✍ Samy Suissa; Marie Hudson; Pierre Ernst 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

## Abstract ## Objective Spontaneous reports of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) treated with leflunomide, a disease‐modifying antirheumatic drug (DMARD), have been appearing recently. To assess this risk, we conducted a population‐based epidemiologic stud